Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 3/2013

Ausgabe 3/2013

Inhaltsverzeichnis ( 17 Artikel )

01.09.2013 | editorial | Ausgabe 3/2013

ASH 2012: “Helping hematologists conquer blood diseases worldwide”

Michael Steurer MD

01.09.2013 | Editorial | Ausgabe 3/2013

Focus on gastrointestinal tumors

Univ.-Prof. Dr. Wolfgang Eisterer

01.09.2013 | review | Ausgabe 3/2013

Personalized medicine for breast cancer: dream or reality?

Lina Pugliano, Dimitrios Zardavas, Martine Piccart MD

01.09.2013 | short review | Ausgabe 3/2013

ASH Annual Meeting 2012—Chronic Myeloid Leukemia Update

Prof. Dr. Andreas L. Petzer

01.09.2013 | short review | Ausgabe 3/2013

Aggressive lymphoma at ASH 2012: new standards and new perspectives

Thomas Nösslinger, Thomas Nösslinger MD

01.09.2013 | short review | Ausgabe 3/2013

ASH 2012: allogeneic stem cell transplantation

Johannes Clausen MD

01.09.2013 | short review | Ausgabe 3/2013

ASH 2012 update chronic lymphocytic leukemia—the best is yet to come

Lukas Weiss, Thomas Melchardt, Richard Greil, Georg Hopfinger

01.09.2013 | short review | Ausgabe 3/2013

Philadelphia-negative myeloproliferative neoplasms at the 2012 ASH meeting: a personal summary

Stefan Schmidt

01.09.2013 | short review | Ausgabe 3/2013

Acute myeloid leukemia: highlights from the 54th ASH meeting held in Atlanta, Georgia

Elisabeth Koller MD

01.09.2013 | short review | Ausgabe 3/2013

Georgia on my mind: multiple myeloma highlights at ASH 2012

Dr. Wolfgang Willenbacher MD, Dr. Ella Willenbacher MD

01.09.2013 | short review | Ausgabe 3/2013

What’s new in Hodgkin’s lymphoma: ASH 2012 and more

Thomas Melchardt, Lukas Weiss, Richard Greil, Priv. Doz. Alexander Egle MD

01.09.2013 | short review | Ausgabe 3/2013

Cancer-associated venous thromboembolism: risk assessment, prevention, and treatment

Clemens Feistritzer MD

01.09.2013 | short review | Ausgabe 3/2013

Biosimilars versus generics: scientific basics and clinical implications

Harald H. Sitte MD, Michael Freissmuth

01.09.2013 | short review | Ausgabe 3/2013

Controversial issues in the therapy of oesophageal carcinoma

PD Dr. med. Thomas Ruhstaller, Michael Stahl

01.09.2013 | short review | Ausgabe 3/2013

Radiofrequency ablation in gastrointestinal cancer: obstacles and goals

Gerlig Widmann MD, Reto Bale

01.09.2013 | short review | Ausgabe 3/2013

Molecular therapies of colorectal cancer: where will we go from here?

Gerald Prager MD

01.09.2013 | short review | Ausgabe 3/2013

Upper gastrointestinal cancer: POST ASCO 2013

Ewald Wöll MD

Aktuelle Ausgaben